C‐terminal variants of the P2X7 receptor are associated with prostate cancer progression and bone metastasis – evidence from clinical and pre‐clinical data-Reference-Cited by-同舟云学术

C‐terminal variants of the P2X7 receptor are associated with prostate cancer progression and bone metastasis – evidence from clinical and pre‐clinical data

Published:2022-12-29 Issue:3 Volume:43 Page:400-404
ISSN:2523-3548
Container-title:Cancer Communications
language:en
Short-container-title:Cancer Communications

Author:

Song Haiping¹,Arredondo Carrera Hector Manuel²^ORCID,Sprules Alexandria²^ORCID,Ji Ying¹,Zhang Tongsong¹,He Jiepei²,Lawrence Eleanor²,Gartland Alison²^ORCID,Luo Jian³^ORCID,Wang Ning²^ORCID

Affiliation:

1. Department of Internal Medicine‐Oncology Qingdao Tumor Hospital The Second Affiliated Hospital of Medical College of Qingdao University Qingdao Shandong 266042 P. R. China

2. The Mellanby Centre for Musculoskeletal Research Department of Oncology and Metabolism The University of Sheffield Sheffield South Yorkshire S10 2RX UK

3. Yangzhi Rehabilitation Hospital (Sunshine Rehabilitation Centre) Tongji University School of Medicine Shanghai 201619 P. R. China

Funder

Royal Society

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cac2.12391

Reference10 articles.

1. P2X7 in Cancer: From Molecular Mechanisms to Therapeutics